{
    "title": "China allows COVID boosters of different technologies than primary shots",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10530063/China-allows-COVID-boosters-different-technologies-primary-shots.html",
    "date": "2022-02-19",
    "keywords": [
        "booster",
        "vaccine",
        "omicron",
        "sinopharm",
        "sinovac",
        "shot",
        "antibody",
        "coronavirus",
        "immunity",
        "china",
        "wu",
        "news",
        "zhifeis",
        "protein",
        "effort",
        "immunisation",
        "jabs",
        "population",
        "pivot",
        "zero",
        "strategy",
        "travel",
        "mass",
        "effectiveness",
        "month",
        "cansino",
        "unit",
        "health",
        "commission",
        "official",
        "liangyou",
        "saturday",
        "onethird",
        "feb",
        "data",
        "briefing",
        "hong",
        "kong",
        "research",
        "httpswwwnaturecomarticless4159102101677z",
        "sinovacs",
        "coronavac",
        "response",
        "delta",
        "trial",
        "study",
        "bbibpcorv",
        "level",
        "outbreak",
        "tianjin",
        "anyang",
        "infection",
        "rate",
        "vaccination",
        "yiming",
        "expert",
        "team",
        "chinas",
        "covid",
        "development",
        "work",
        "group",
        "shao",
        "cansinobio",
        "cold",
        "virus",
        "material",
        "reporting",
        "roxanne",
        "liu",
        "andrew",
        "galbraith",
        "editing",
        "mallard"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}